Opko pays $10mm in cash for oligonucleotide developer Curna
- Antisense, Oligonucleotides
- Large Molecule
- Intra-Biotech Deal
- Full Acquisition
- Acquisition of Private Biotech
- Payment Includes Cash
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.